H3): the device was discarded, thus no investigation could be completed.H6): cardiac perforation is a known risk of complication with use of the lld submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.
|
A lead extraction procedure commenced to remove a right atrial (ra) lead due to lead failure.A right ventricular (rv) and a left ventricular (lv) were present in the patient as well, but were not targeted for extraction.A spectranetics lead locking device (lld ez) was inserted into the ra lead to provide traction.Using a spectranetics glidelight laser sheath, advancement was made past the subclavian vein, where progress stalled.A spectranetics 11f tightrail rotating dilator sheath was used next, which made steady progress, and the lead released.Approximately 20-30 seconds later, a small pericardial effusion was detected via transesophageal echocardiography (tee).An ra perforation was suspected because the patient''s chest was not opened and an injury location could not be confirmed.Rescue efforts began, including pericardiocentesis.The re-implantation of a new lead was successful, and the patient survived the procedure.This report captures the lld ez providing traction to the ra lead when the suspected perforation occurred, requiring intervention.There was no alleged malfunction of any spectranetics devices in use during the procedure.
|